ID

Gender Diagnosis Age of Onset Presenting Symptoms C3 C3/C2 Mutation Variant Remarks Hom. /Het. Dom.
Nucleotide Amino acid
1 M MMA 4 months Delayed motor and mental development, lethargy, tachypnea, metabolic acidosis, hyperammonemia, vomiting, fever, anemia and diarrhea 30.11 0.47 c.15G>A p.K5Ka Silent Hom ML
c.165C>A p.N55Ka Missense Het NT
c.323G>A p.R108Hb Missense Hom (βα)8
5 M MMA 3 Days Delayed motor and mental development,  lethargy, bad obstetric history 11.4 0.7 c.15G>A p.K5K Silent Het ML
9 F MMA 6 Days Tachypnea, disturbed conscious level then coma, loss of acquired motor and mental development, lethargy, hyperammonemia, anemia and admitted into PICU. 26.3 0.67 c.165C>A p.N55K Missense Het NT
10 M MMA NR Enlarged liver, otitis media, tonsillitis, fever, developmental regression, loss of motor milestone, vomiting, metabolic acidosis and coma NR NR c.7del p.R3EfsX14a Frame Shift Hom ML
11 M PA 3 Days Hyperammonemia, jaundice, anemia and NICU admission 35.9 0.49 c.15G>A p.K5K Silent Het ML
c.165C>A p.N55K Missense Het NT
MMA- methylmalonic aciduria, PA- propionic aciduria, PICU- pediatric intensive care unit, NICU- neonatal intensive care unit, NR- not recorded, C3- propionylcarnitine,
C3:C2- acetylcarnitine: propionylcarnitine
aNovel mutations
bMutation involves CpG dinucleotide
Normal Reference values; C3<4.0 μmol/L, C3:C2<0.30
Table 2: Mutations and polymorphisms identified in this study in the coding exon 2 of MUT gene and phenotype/genotype correlation with the homozygous mutations.